A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Actym Therapeutics, Inc.
Actym Therapeutics, Inc.
Elevation Oncology
Pfizer
Tocagen Inc.
University of Wisconsin, Madison
CureOne
University Health Network, Toronto
Masonic Cancer Center, University of Minnesota
Case Comprehensive Cancer Center